In the latest for cancer treatments, a US based pharmaceuticals company, Novartis has developed the first gene therapy treatment for B-cell Acute Lymphoblastic Leukemia (ALL).
Novartis AG's pioneering cancer drug won the backing of US Food and Drug Administration panel on Wednesday, 12 July.
The treatment is the first ever therapy that helps a patient fight cancer by genetically altering one’s own cells and transforming them into a ‘living drug’ as per the scientists. It will empower the immune system to eventually keep cancer out of the body.